bioMmune Technologies Inc. Announces Appointment of Directors

VANCOUVER, BRITISH COLUMBIA–(Marketwired – Dec. 9, 2015) – bioMmune Technologies Inc. (“bioMmune” or the “Company”) (TSX VENTURE:IMU), a company focused on harnessing the body’s immune system to fight cancer and autoimmune diseases, is pleased to announce that Patrick W. Gray, PhD and Reinhard Gabathuler, PhD have been elected as directors of the Company at its Annual and Special Meeting held on December 8, 2015 in Vancouver, B.C. Dr. Gray has spent 35 years in the biotechnology industry, focusing on drug discovery for critical diseases. He has a passion for working in small companies with aggressive timelines — Genentech, ICOS, Macrogenics, Nura and Accelerator were all less than 60 employees when he joined. Dr. Gray’s career accomplishments include the first cloning and characterization of Hepatitis B surface antigen, Interferon-gamma, multiple Interferon-alpha…

Link to Full Article: bioMmune Technologies Inc. Announces Appointment of Directors

Pin It on Pinterest

Share This